Cargando…

Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report

Patients with cancer have a higher risk of severe COVID-19, and expert consensus advocates for COVID-19 vaccination in this population. Some cases of autoimmune hepatitis have been described after the administration of COVID-19 vaccine in the people in apparently good health. Immune checkpoint inhib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lasagna, Angioletta, Lenti, Marco Vincenzo, Cassaniti, Irene, Sacchi, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196259/ https://www.ncbi.nlm.nih.gov/pubmed/35694999 http://dx.doi.org/10.2217/imt-2021-0342

Ejemplares similares

Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir
por: Lasagna, Angioletta, et al.
Publicado: (2022)

Long-COVID in Patients with Cancer Previously Treated with Early Anti-SARS-CoV-2 Therapies in an Out-of-Hospital Setting: A Single-Center Experience
por: Lasagna, Angioletta, et al.
Publicado: (2023)

Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up
por: Lasagna, Angioletta, et al.
Publicado: (2023)

Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment
por: Lasagna, Angioletta, et al.
Publicado: (2022)

Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study
por: Lasagna, Angioletta, et al.
Publicado: (2023)

Impact of proton pump inhibitors on the onset of gastrointestinal immune‐related adverse events during immunotherapy
por: Lasagna, Angioletta, et al.
Publicado: (2023)

Autoimmune hepatitis triggered by SARS-CoV-2 vaccination
por: Vuille-Lessard, Élise, et al.
Publicado: (2021)

Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM)
por: Pedrazzoli, P., et al.
Publicado: (2023)

Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research
por: Lasagna, Angioletta, et al.
Publicado: (2021)

Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children
por: Ricciardi, Alessandra, et al.
Publicado: (2022)

SARS‐CoV‐2 infection as a trigger of autoimmune response
por: Sacchi, Maria C., et al.
Publicado: (2021)

SARS‐CoV‐2 vaccinations can trigger polyradiculitis
por: Finsterer, Josef, et al.
Publicado: (2022)

SARS-CoV-2 positivity in rectal swabs: implication for possible transmission
por: Novazzi, Federica, et al.
Publicado: (2020)

SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders
por: Benazzo, Marco, et al.
Publicado: (2020)

Adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein
por: Khan, Muhammad S, et al.
Publicado: (2022)

SARS-CoV-2 vaccination triggered Guillain-Barre syndrome
por: Scorza, Fulvio A, et al.
Publicado: (2022)

Prurigo Nodularis Eruption Triggered by SARS-CoV-2 Vaccine
por: Barnawi, Ghassan, et al.
Publicado: (2022)

Does maternal SARS-CoV-2 infection or SARS-CoV-2 vaccination trigger an inflammatory response in the fetus?
por: Alhousseini, Ali, et al.
Publicado: (2022)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice
por: Kim, Eun, et al.
Publicado: (2023)

Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns
por: Cassaniti, Irene, et al.
Publicado: (2021)

[Translated article] RF-SARS-CoV-2 Vaccination and Immunotherapy in Dermatology
por: Rodríguez-Villa Lario, A., et al.
Publicado: (2022)

Juvenile Dermatomyositis Triggered by SARS-CoV-2
por: Liquidano-Perez, Eduardo, et al.
Publicado: (2021)

Facing SARS-CoV-2 outbreak in immunotherapy era
por: Citarella, Fabrizio, et al.
Publicado: (2020)

An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology
por: Gresham, Louise M., et al.
Publicado: (2021)

SARS-CoV-2 Vaccine Response in Patients With Autoimmune Hepatitis
por: Schneider, Lisa, et al.
Publicado: (2022)

Drug induced hepatitis and SARS-CoV-2 vaccination: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

CAR Macrophages for SARS-CoV-2 Immunotherapy
por: Fu, Wenyan, et al.
Publicado: (2021)

The SARS-CoV-2 as an instrumental trigger of autoimmunity
por: Dotan, Arad, et al.
Publicado: (2021)

SARS-CoV-2-triggered lymphocytic colitis
por: Nassar, Islam Osama, et al.
Publicado: (2021)

SARS-CoV-2 triggering autoimmune diseases
por: Mobasheri, Leila, et al.
Publicado: (2022)

In reply to: “A COVID-19 screening tool for oncology telephone triage”
por: Lasagna, Angioletta, et al.
Publicado: (2020)

Haemolytic anemia triggered by SARS-CoV-2 in patient with hereditary spherocytosis()
por: Barberá-Pérez, Paula María, et al.
Publicado: (2021)

COVID-19 and breast cancer: may the microbiome be the issue?
por: Lasagna, Angioletta, et al.
Publicado: (2020)

Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
por: Schubert, Maren, et al.
Publicado: (2022)

Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy
por: Giordano, Giulia, et al.
Publicado: (2021)

SARS-CoV-2 vaccines: Lights and shadows
por: Angeli, Fabio, et al.
Publicado: (2021)

Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development
por: Cohen, Samuel A., et al.
Publicado: (2020)

Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
por: Speeckaert, Reinhart, et al.
Publicado: (2021)

Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy
por: Spiliopoulou, Pavlina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fijmh6jvrlr3a21auta7gg3qll